The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use a concentration of 0.625 µg/ml.
Nalidixic acid (C12H12N2O3, systematic name 1-ethyl-7-methyl-4-oxo-[1,8]naphthyridine-3-carboxylic acid) is a quinolone antibiotic which inhibits DNA-gyrase. It is used in the treatment of urinary tract infections as it reaches high levels in the urine and is effective over the entire urinary pH range.
References for Anti-Nalidixic Acid antibody (ab58943)
has not yet been referenced specifically in any publications.
Publishing research using ab58943? Please let us know so that we can cite the reference in this datasheet.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up